SKLLR's Achievement at RGC's General Research Fund (GRF) 2026/27 Exercise
30 June 2026
SKLLR is pleased to share the fantastic news that 11 Principal Investigators (PIs) and Associate Members (AMs) of SKLLR have been awarded the Research Grants Council (RGC)’s General Research Fund (GRF) for the 2026/27 exercise.
Below are the details of the awarded projects:
| PI | Project Title | Project No. |
|---|---|---|
| Professor DY JIN | Roles of CYLD deubiquitinase in Epstein-Barr virus infection | 17131326 |
| Professor Heidi GS LING | Investigate how hyperglycemia-induced neutrophil reprogramming promotes tumor progression in Type 2 diabetes | 17125826 |
| Professor PT LIU | Establishment of the Next-Generation Porcine Pluripotent Stem Cells | 17119126 |
| Professor Stephanie KY MA | Deciphering the role of ROR1+ liver cancer cells in CAF activation through BSG (CD147): implications for stemness and therapy resistance | 17122426 |
| Professor XY GUAN | Characterization of SRSF9 as a druggable regulator of CD8⁺ T-cell dysfunction and resistance to PDL1/VEGF-A dual blockade in hepatocellular carcinoma | 17123526 |
| Professor Loey LY MAK | Response-guided therapy with sequential PEG-IFN𝛼 among recipients of AHB-137, an unconjugated antisense oligonucleotide: An open-label phase II study for patients with chronic hepatitis B infection | 17113126 |
| Dr Yu-Man TSUI | Identification of ACSL4 in the tumour interstitial fluid in shaping an immunosuppressive tumour microenvironment through the CEACAM1-enriched extracellular vesicles in hepatocellular carcinoma | 17115626 |
| Professor Carmen CL WONG | Harnessing Methionine Dependency in HCC: Dietary Intervention for Tumor Suppression and Immune Activation | 17110026 |
| Professor Jack CM WONG | Targeting ADAT2-Mediated A-to-I tRNA Editing to Disrupt Serine/Glycine/One-Carbon Metabolism in Hepatocellular Carcinoma | 17116226 |
| Professor Judy WP YAM | The uncovered role of MED8 in small extracellular vesicles in the progression of hepatocellular carcinoma | 17120526 |
| Professor TT CHEUNG | The role of CENP-A targeting in epigenetic correction and drug development in hepatocellular carcinoma – therapeutic mechanism and precision modeling | 17113626 |
We would also like to take this opportunity to extend our sincere appreciation to all members who have contributed to other projects related to liver research.
Heartfelt congratulations to all the awardees!
